We have developed the world’s first and market-leading organ-on-chip platform, powered by pharmaceutical-scale engineering and advanced image-based AI. This technology addresses a critical gap in preclinical research by providing physiologically realistic human organ models, enabling more predictive drug discovery while reducing reliance on animal testing.
90% vs. 50-65% with live animals
Engineering
Economical microfluidic chips and perfusion solution that balance complexity and throughput.
Imaging
Multiple cell staining methods and high content imaging analysis to accurately capture 3D morphology.
outreach@xellarbio.com
500 Rutherford Ave, Boston, MA 02129
Leave us a request and we will contact you soon.